Diseases, Conditions, Syndromes

Review examines efficacy of PPI Tx for esophageal eosinophilia

(HealthDay)—About half of patients with symptomatic esophageal eosinophilia have clinicohistologic remission with proton pump inhibitor (PPI) therapy, according to a review published in the January issue of Clinical Gastroenterology ...

Diabetes

Sanofi, Medtronic join on diabetes drugs, devices

French drugmaker Sanofi and U.S. medical device manufacturer Medtronic Inc. have joined in a project to develop new combinations of drugs and devices for diabetes care.

Medications

Acid reflux drugs linked to increased fracture risk in kids

Proton pump inhibitors—a widely used class of drugs used to treat acid reflux and related symptoms—may lead to an increased risk of fractures in children and adolescents, reports a study in the Journal of Pediatric Gastroenterology ...

Diseases, Conditions, Syndromes

Researchers identify new heartburn target

Acid reflux and heartburn affect more than 20 percent of the U.S. population, but common medications to treat the disease might not work for a large portion people who suffer from the diseases.

Diseases, Conditions, Syndromes

PPI-gastric cancer link remains after H. pylori eradication

(HealthDay)—Long-term proton pump inhibitor (PPI) use is associated with increased risk of gastric cancer (GC) even after Helicobacter pylori (HP) eradication therapy, according to a study published online Oct. 31 in Gut.

page 25 from 39